Main menu

Skip to primary content
Skip to secondary content
    • World map    |
    • Rationale behind WSN    |
    • Highlight    |
    • 2019
    • |
    • 2018
    • |
    • 2017
    • |
    • 2016
    • |
    • 2015
    • |
    • 2014
    • |
    • 2013
    • |
    • Funders    |
    • Partners    |
    • Studies
Private Access |
  • Contact us
  • Legal notices
  • Credits
STUDIES
  • Academic
  • Industries

A Multi-Center Single Agent Phase II Study of the Efficacy of Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor (PVNS US)

From adminadmin, 02.02.2012, in Academic
Principal Investigator:
Andrew J. WAGNER
Phase: II
Category: Academic




Search